Today: 3 February 2026
Subscribe

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Procter & Gamble stock rises as defensive staples rally on Powell probe; PG earnings ahead

Procter & Gamble stock rises as defensive staples rally on Powell probe; PG earnings ahead

NEW YORK, Jan 12, 2026, 14:10 EST — Regular session Shares of The Procter & Gamble Company climbed roughly 1% to $143.29 Monday afternoon, outpacing the wider market as investors favored consumer-staples stocks. The Consumer Staples Select Sector SPDR Fund gained around 1.2%, while Colgate-Palmolive, Kimberly-Clark, and Unilever also saw their shares rise. The SPDR S&P 500 ETF edged up…
12 January 2026
·····
D-Wave Quantum stock edges up as deal clock ticks — what QBTS traders are watching next

D-Wave Quantum stock edges up as deal clock ticks — what QBTS traders are watching next

New York, Jan 12, 2026, 14:17 EST — Regular session D-Wave Quantum Inc. shares edged up 0.8% to $28.33 in Monday afternoon trading, continuing the volatile early-year trend for U.S.-listed quantum computing stocks. The shift is significant as D-Wave navigates a crucial transition: expanding from its specialty in “annealing” systems—designed for specific optimization tasks—into the realm of “gate-model” quantum computers,…
12 January 2026
·······
Uber stock dips before bellwether assault trial and a profit-metric makeover

Uber stock dips before bellwether assault trial and a profit-metric makeover

New York, Jan 12, 2026, 14:09 ET — Regular session Shares of Uber Technologies (UBER.N) dipped 0.2% to $85.28 in Monday afternoon trading, after fluctuating between $83.78 and $85.47 earlier in the session. A court order reveals the company’s first federal bellwether trial linked to passenger sexual-assault allegations will kick off Jan. 13 in Phoenix. The lawsuit, filed by Oklahoma…
12 January 2026
····
UnitedHealth stock slides after Senate Medicare report; UNH investors eye Jan. 27 outlook

UnitedHealth stock slides after Senate Medicare report; UNH investors eye Jan. 27 outlook

NEW YORK, Jan 12, 2026, 13:48 EST — Regular session Shares of UnitedHealth Group Incorporated dropped Monday following a U.S. Senate report accusing the insurer of using aggressive tactics to boost Medicare Advantage payments. The stock dipped 1.5% to $338.89 in early afternoon trading. (Reuters) The report arrives amid heightened scrutiny of managed-care stocks, with investors digesting the potential for…
12 January 2026
····
Thermo Fisher (TMO) stock slips after COO exit disclosed; AI lab deals put focus on JPM talk

Thermo Fisher (TMO) stock slips after COO exit disclosed; AI lab deals put focus on JPM talk

New York, Jan 12, 2026, 13:50 EST — Regular session Shares of Thermo Fisher Scientific dropped Monday following a regulatory filing revealing that its chief operating officer plans to exit later this quarter amid a reshuffle of the company’s senior leadership. The stock slipped 1.8% to $607.56, cooling off from an earlier high of $624.14. The management shake-up hits amid…
12 January 2026
·····
Cisco stock slips as Supreme Court case and inflation data loom — what to know about CSCO

Cisco stock slips as Supreme Court case and inflation data loom — what to know about CSCO

New York, Jan 12, 2026, 13:53 EST — Regular session underway. Cisco Systems (CSCO.O) shares slipped slightly Monday, as a U.S. Supreme Court docket update renewed focus on a lawsuit alleging the company helped Chinese authorities surveil Falun Gong practitioners. Early afternoon trading saw the stock down roughly 0.2% at $73.73. (SCOTUSblog) The legal cloud looms at a tricky time…
12 January 2026
····
Coca-Cola stock ticks lower as CPI looms; KO investors eye rates and February earnings

Coca-Cola stock ticks lower as CPI looms; KO investors eye rates and February earnings

New York, Jan 12, 2026, 13:58 EST — Regular session Coca-Cola shares slipped 0.2% to $70.39 during midday trading in New York on Monday, fluctuating between $70.27 and $70.96. The stock lagged behind the wider rebound in consumer staples, where the Consumer Staples Select Sector SPDR Fund gained roughly 1.1%. The S&P 500 ETF SPY edged up modestly, and PepsiCo…
12 January 2026
····
RTX stock rises after Airbus flags Pratt & Whitney engine delays, with Jan 27 earnings ahead

RTX stock rises after Airbus flags Pratt & Whitney engine delays, with Jan 27 earnings ahead

New York, Jan 12, 2026, 13:49 EST — Regular session RTX shares climbed 1.7% to $191.74 in Monday afternoon trading despite a fresh warning from Airbus about delayed jet-engine deliveries from RTX’s Pratt & Whitney unit. Airbus noted it hasn’t settled with Pratt & Whitney on the volume of engines needed “for the foreseeable future,” while RTX offered no immediate…
12 January 2026
····
Lockheed Martin stock today: LMT edges up as defense names catch a safety bid

Lockheed Martin stock today: LMT edges up as defense names catch a safety bid

New York, Jan 12, 2026, 13:40 EST — Regular session Lockheed Martin Corp shares climbed $2.70, roughly 0.5%, to $545.62 on Monday, tracking gains across major defense contractors as broader markets showed volatility. RTX advanced around 1.6%, Northrop Grumman added 1.5%, and General Dynamics rose 1.3%. Investors are shifting toward defense, searching for a “safe-haven” as uncertainty builds ahead of…
12 January 2026
·····
Carvana stock ticks up near $470 as Wall Street waits on CPI and rate signals

Carvana stock ticks up near $470 as Wall Street waits on CPI and rate signals

New York, January 12, 2026, 13:30 EST — The regular session is underway. Carvana Co. shares rose Monday, extending a strong start to the year that has kept the online used-car retailer close to its recent peaks. The stock gained 1.6%, settling at $470.52 after swinging between $455.32 and $470.92 during the session. The gain arrived after the broader market…
12 January 2026
····
AbbVie stock slips after $650 million RemeGen cancer-drug deal and Arizona plant buy

AbbVie stock slips after $650 million RemeGen cancer-drug deal and Arizona plant buy

New York, January 12, 2026, 13:31 EST — Regular session AbbVie Inc shares slipped Monday following news of a new collaboration with China’s RemeGen to co-develop an experimental solid-tumor drug, as the company ramps up efforts to expand its cancer portfolio via licensing deals. By 1:30 p.m. EST, AbbVie was down 0.6% at $218.81. (Reuters) Investors are focused on how…
12 January 2026
·····
KLA stock touches a 52-week high as chip equipment shares climb ahead of earnings

KLA stock touches a 52-week high as chip equipment shares climb ahead of earnings

New York, Jan 12, 2026, 13:36 ET — Regular session KLA Corp shares climbed roughly 1.9% to $1,426.46 on Monday, hitting $1,428.51—marking their highest point in 52 weeks—as demand for chip-equipment stocks remained strong. (Investing) KLA’s quarterly results carry weight, as they often set the tone for semiconductor spending forecasts early in the year. The company plans to release its…
12 January 2026
·····
1 … 321 322 323 324 325 … 946

Stock Market Today

  • Needham Cuts Marvell Technology Price Target Amid Mixed Analyst Ratings
    February 3, 2026, 8:34 AM EST. Needham & Company LLC lowered its price target for Marvell Technology (NASDAQ:MRVL) to $118 from $120 while maintaining a buy rating. This signals a less optimistic outlook despite a potential 50% upside. Other major firms showed varying views: JPMorgan raised its target to $130 with an overweight rating, Morgan Stanley set $112, and Wells Fargo increased theirs substantially to $135. The stock recently traded around $78.57 with a market cap of $66.63 billion. Marvell reported quarterly earnings of $0.76 per share, beating estimates slightly, with revenue up 36.8% year-over-year. The semiconductor company's 1-year stock range spans from $47.08 to $121.81. Analyst consensus remains moderately positive, but recent insider selling adds caution to the outlook.
Go toTop